Monterola, Ahmerson .

HRN: 27-93-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/09/2025
10/16/2025
IV DRIP
650mg
Q6h
UTI; T/C Otitis Media
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: